Over the 90-day window ending February 15, 2026, HCW Biologics's three dominant insider ownership positions are held by Chief Executive Officer Hing C Wong (501.91K shares), Chief Financial Officer Rebecca Byam (43.01K shares), Director Scott T Garrett (32.20K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Hing C Wong | Chief Executive Officer | 501,911 | 20 May, 2025 |
| Scott T Garrett | 32,201 | 20 May, 2025 | |
| Peter Rhode | Nan | 1,938 | 11 Dec, 2023 |
| Jin-An Jiao | Vp Of Development | 1,129 | 02 Jun, 2022 |
| Rebecca Byam | Chief Financial Officer | 43,010 | 09 May, 2025 |
| Lisa M. Giles | 895 | 22 Feb, 2024 | |
| Lee Flowers | Svp Of Business Development | 5,720 | 09 May, 2025 |
| Gary M Winer | 4,075 | 20 May, 2025 | |
| Rick S. Greene | 2,066 | 09 May, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 May, 2025 | Scott T Garrett | Common Stock | A | 13,423 | $7.45 | 25,505 | D | P |
| 16 May, 2025 | Gary M Winer | Common Stock | A | 1,342 | $7.45 | 4,075 | D | P |
| 16 May, 2025 | Hing C Wong | Common Stock | A | 8,054 | $7.45 | 501,911 | D | P |
| 08 May, 2025 | Scott T Garrett | Common Stock | A | 5,385 | $26.00 | 12,082 | D | P |
| 08 May, 2025 | Gary M Winer | Common Stock | A | 2,308 | $26.00 | 2,733 | D | P |
| 08 May, 2025 | Lee Flowers | Common Stock | A | 962 | $26.00 | 5,720 | D | P |
| 08 May, 2025 | Rebecca Byam | Common Stock | A | 8,462 | $26.00 | 43,010 | D | P |
| 08 May, 2025 | Hing C Wong | Common Stock | A | 92,500 | $26.00 | 493,857 | D | P |
| 08 May, 2025 | Rick S. Greene | Common Stock | A | 962 | $26.00 | 2,066 | D | P |
| 20 Feb, 2024 | Scott T Garrett | Common Stock | A | 142,858 | $1.40 | 6,696 | I | A |
| 20 Feb, 2024 | Lisa M. Giles | Common Stock | A | 35,715 | $1.40 | 895 | D | A |
| 20 Feb, 2024 | Lisa M. Giles | - | - | 895 | D | |||
| 20 Feb, 2024 | Lee Flowers | Common Stock | A | 71,429 | $1.40 | 4,756 | D | A |
| 20 Feb, 2024 | Rebecca Byam | Common Stock | A | 760,714 | $1.40 | 34,548 | D | A |
| 20 Feb, 2024 | Hing C Wong | Common Stock | A | 739,288 | $1.40 | 401,354 | D | A |
| 20 Feb, 2024 | Rick S. Greene | Common Stock | A | 35,714 | $1.40 | 1,103 | D | A |
| 11 Dec, 2023 | Peter Rhode | Common Stock | A | 14,000 | $0.14 | 1,938 | D | M |
| 08 Dec, 2023 | Lee Flowers | Common Stock | A | 7,501 | $0.14 | 2,970 | D | M |
| 17 Nov, 2023 | Peter Rhode | - | - | 1,588 | D | |||
| 17 Nov, 2023 | Peter Rhode | Common Stock | A | 15,000 | $0.14 | 1,588 | D | M |